Income Statement (TTM)
OncoCyte Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 4 | 5 | 2 | 1 | -0 | -1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 4 | 4 |
| Change (%) | 70.55 | 91.12 | 81.24 | 10.19 | -52.64 | -33.85 | -123.31 | 270.50 | -176.27 | -8.66 | 25.83 | 32.88 | 2.73 | -8.05 | -25.98 | -30.69 | 165.30 | 104.31 | 10.77 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 2 | 2 | 3 | 4 | 1 | 0 | -1 | -2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Change (%) | 62.86 | 31.27 | 39.84 | 7.61 | -80.98 | -90.82 | -1,823.44 | 49.50 | -153.37 | 18.18 | -1.35 | -15.11 | 15.04 | -15.57 | -16.19 | -16.36 | 77.57 | 66.19 | 7.77 | |
| % of Revenue | 159.75 | 152.55 | 104.78 | 80.84 | 78.95 | 31.71 | 4.40 | 325.37 | 131.29 | 91.86 | 118.86 | 93.19 | 59.54 | 66.67 | 61.22 | 69.31 | 83.64 | 55.98 | 45.54 | 44.30 |
| Gross Operating Profit | -0 | -1 | -0 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | -0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 2 | 2 |
| Change (%) | 50.00 | -82.63 | -827.03 | 21.07 | 53.63 | -7.40 | -45.04 | -48.56 | -80.15 | -311.54 | -145.45 | 689.33 | -15.37 | 6.99 | -41.42 | -63.06 | 613.79 | 152.78 | 13.28 | |
| % of Revenue | -59.75 | -52.55 | -4.78 | 19.16 | 21.05 | 68.29 | 95.60 | -225.37 | -31.29 | 8.14 | -18.86 | 6.81 | 40.46 | 33.33 | 38.78 | 30.69 | 16.36 | 44.02 | 54.46 | 55.70 |
| SG&A | 22 | 22 | 23 | 26 | 29 | 20 | 19 | 16 | 14 | 22 | 20 | 18 | 16 | 14 | 13 | 12 | 13 | 14 | 15 | 16 |
| Change (%) | 1.88 | 4.02 | 12.75 | 10.98 | -30.21 | -5.42 | -14.77 | -16.64 | 57.14 | -8.39 | -8.08 | -13.05 | -14.16 | -4.34 | -4.60 | 3.44 | 10.72 | 5.67 | 5.67 | |
| % of Revenue | 3,090.32 | 1,846.05 | 1,004.78 | 625.07 | 629.56 | 927.75 | 1,326.48 | -4,848.97 | -1,091.00 | 2,247.70 | 2,254.51 | 1,647.05 | 1,077.79 | 900.60 | 936.90 | 1,207.53 | 1,802.26 | 752.15 | 389.02 | 371.08 |
| R&D | 10 | 9 | 11 | 10 | 10 | 5 | 3 | 3 | 2 | 7 | 7 | 7 | 8 | 9 | 9 | 10 | 10 | 10 | 10 | 11 |
| Change (%) | -8.65 | 12.75 | -6.48 | 5.30 | -54.12 | -28.20 | -2.70 | -49.78 | 332.05 | 1.65 | -2.27 | 9.96 | 15.00 | 2.02 | 1.90 | 6.57 | -2.89 | 5.38 | 8.79 | |
| % of Revenue | 1,447.12 | 775.16 | 457.31 | 235.97 | 225.51 | 218.47 | 237.14 | -989.68 | -134.16 | 759.92 | 845.71 | 656.86 | 543.54 | 608.45 | 675.11 | 929.33 | 1,429.06 | 523.07 | 269.79 | 264.95 |
| OpEx | 33 | 34 | 37 | 41 | 46 | 26 | 23 | 17 | 12 | 30 | 28 | 26 | 25 | 24 | 23 | 23 | 24 | 25 | 27 | 29 |
| Change (%) | 0.71 | 8.83 | 11.84 | 11.37 | -43.19 | -12.98 | -22.83 | -33.94 | 158.54 | -5.14 | -6.29 | -6.80 | -3.68 | -2.35 | -2.39 | 4.12 | 6.52 | 8.01 | 6.90 | |
| % of Revenue | 4,697.19 | 2,773.77 | 1,579.43 | 974.67 | 985.11 | 1,181.62 | 1,554.40 | -5,144.84 | -917.36 | 3,109.50 | 3,229.37 | 2,405.18 | 1,686.94 | 1,581.57 | 1,679.59 | 2,214.76 | 3,327.36 | 1,335.89 | 706.25 | 681.54 |
| Operating Income | -33 | -33 | -34 | -37 | -41 | -24 | -21 | -18 | -13 | -29 | -27 | -25 | -23 | -22 | -22 | -22 | -23 | -23 | -23 | -25 |
| Change (%) | -0.81 | 5.75 | 7.15 | 11.50 | -42.12 | -11.05 | -15.92 | -28.13 | 125.63 | -5.03 | -7.31 | -8.52 | -4.09 | -1.97 | -0.90 | 5.77 | 1.60 | 0.22 | 6.26 | |
| % of Revenue | -4,597.19 | -2,673.77 | -1,479.43 | -874.67 | -885.11 | -1,081.62 | -1,454.40 | 5,244.84 | 1,017.36 | -3,009.50 | -3,129.37 | -2,305.18 | -1,586.94 | -1,481.57 | -1,579.59 | -2,114.76 | -3,227.36 | -1,235.89 | -606.25 | -581.54 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 44.00 | 18.25 | -8.72 | -10.29 | -14.34 | -18.18 | -16.37 | -25.17 | -22.43 | -22.89 | -10.94 | -0.00 | -8.77 | 7.69 | -10.71 | 34.00 | 25.37 | 16.67 | 17.35 | |
| % of Revenue | -24.54 | -20.72 | -12.82 | -6.46 | -5.26 | -9.51 | -11.76 | 42.18 | 8.52 | -8.66 | -7.31 | -5.18 | -3.90 | -3.46 | -4.05 | -4.89 | -9.45 | -4.47 | -2.55 | -2.70 |
| Net Income | -32 | -30 | -26 | -28 | -35 | -64 | -70 | -68 | -64 | -73 | -60 | -60 | -57 | -28 | -40 | -36 | -43 | -61 | -58 | -63 |
| Change (%) | -5.21 | -12.74 | 5.30 | 25.51 | 85.68 | 9.94 | -3.11 | -6.54 | 14.25 | -18.28 | 0.06 | -4.77 | -51.06 | 43.78 | -9.52 | 19.38 | 40.61 | -4.05 | 8.95 | |
| % of Revenue | -4,428.75 | -2,461.51 | -1,123.88 | -652.99 | -743.83 | -2,916.15 | -4,846.56 | 20,140.41 | 5,080.33 | -7,609.81 | -6,808.91 | -5,414.26 | -3,880.18 | -1,848.37 | -2,890.23 | -3,532.75 | -6,085.19 | -3,225.04 | -1,514.57 | -1,489.71 |
Source: Capital IQ
